Cargando…
Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256359/ https://www.ncbi.nlm.nih.gov/pubmed/32282033 http://dx.doi.org/10.1182/blood.2020005992 |
| _version_ | 1783539890548375552 |
|---|---|
| author | DeBaun, Michael R. |
| author_facet | DeBaun, Michael R. |
| author_sort | DeBaun, Michael R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7256359 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72563592020-06-05 Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic DeBaun, Michael R. Blood Letter to BLOOD American Society of Hematology 2020-05-28 2020-12-14 /pmc/articles/PMC7256359/ /pubmed/32282033 http://dx.doi.org/10.1182/blood.2020005992 Text en Copyright © 2020 American Society of Hematology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to BLOOD DeBaun, Michael R. Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic |
| title | Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic |
| title_full | Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic |
| title_fullStr | Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic |
| title_full_unstemmed | Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic |
| title_short | Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic |
| title_sort | initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with sca during the covid-19 pandemic |
| topic | Letter to BLOOD |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256359/ https://www.ncbi.nlm.nih.gov/pubmed/32282033 http://dx.doi.org/10.1182/blood.2020005992 |
| work_keys_str_mv | AT debaunmichaelr initiatingadjunctlowdosehydroxyureatherapyforstrokepreventioninchildrenwithscaduringthecovid19pandemic |